Thera-Zyme

UrT T12 To L2

F
N+ Score52
Vitamins & MineralsServing: 2 Capsule(s)Type: Other Combinations

UrT T12 To L2 by Thera-Zyme is a Vitamins & Minerals supplement, classified as an 'Other Combinations' type, containing 7 ingredients. This product features a blend of botanicals such as Alfalfa (240mg), Horsetail (130mg), Cranberry (110mg), and Uva Ursi (10mg), complemented by a Proprietary Plant Enzyme Blend (81mg). While these ingredients are traditionally used for various purposes, none are present at dosages considered clinically effective based on current research. The product has an N+ Score of 52, earning an F grade and placing it in the below-average tier. This score reflects concerns regarding the overall formulation and ingredient potency. It may appeal to those interested in a broad botanical blend, but its low N+ Score suggests limited evidence-based efficacy.

About This Product

UrT T12 To L2 by Thera-Zyme is a vitamins & minerals supplement containing 7 active ingredients. It has earned an N+ Score of 52/100 (Grade F).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness0/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity71/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • −Missing several expected ingredients for its category

Ingredient Analysis (7 ingredients)

IngredientAmountDose Adequacy
Horsetail130.000 mgN/A
Alfalfa240.000 mgN/A
Cranberry110.000 mgN/A
Uva Ursi10.000 mgN/A
Proprietary Plant Enzyme Blend81.000 mgN/A
Hydrangea50.000 mgN/A
Meadowsweet50.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.